Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Catherine Sánchez, Alejandro Mercado, Héctor R. Contreras, Felipe Carvajal V, Apolo Salgado, Christian Huidobro & Enrique A. Castellón. (2021) Membrane translocation and activation of GnRH receptor sensitize prostate cancer cells to radiation. International Journal of Radiation Biology 97:11, pages 1555-1562.
Read now
Read now
Nicola Arrighi, Serena Bodei, Danilo Zani, Claudio Simeone, Sergio Cosciani Cunico, Cristina Missale, Pierfranco Spano & Sandra Sigala. (2010) Nerve growth factor signaling in prostate health and disease. Growth Factors 28:3, pages 191-201.
Read now
Read now
Christian Doehn, Martin Sommerauer & Dieter Jocham. (2009) Degarelix and its therapeutic potential in the treatment of prostate cancer. Clinical Interventions in Aging 4, pages 215-223.
Read now
Read now
Christian Doehn, Martin Sommerauer & Dieter Jocham. (2009) Degarelix for prostate cancer. Expert Opinion on Investigational Drugs 18:6, pages 851-860.
Read now
Read now
Articles from other publishers (32)
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer
161
204
.
Takashi Ueda, Takumi Shiraishi, Saya Ito, Munehiro Ohashi, Toru Matsugasumi, Yasuhiro Yamada, Atsuko Fujihara, Fumiya Hongo, Koji Okihara & Osamu Ukimura. (2021) Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer. Scientific Reports 11:1.
Crossref
Crossref
Fabrizio Fontana & Patrizia Limonta. (2021) Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer. Cells 10:5, pages 1133.
Crossref
Crossref
Zahra Mortezaei & Ali Khosravi. (2021) New Potential Anticancer Drug-like Compounds for Squamous Cell Lung Cancer Using Transcriptome Network Analysis. Informatics in Medicine Unlocked, pages 100599.
Crossref
Crossref
Fabrizio Fontana, Monica Marzagalli, Marina Montagnani Marelli, Michela Raimondi, Roberta Moretti & Patrizia Limonta. (2020) Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions. International Journal of Molecular Sciences 21:24, pages 9511.
Crossref
Crossref
H�ctor Contreras, Fernanda L�pez‑Moncada & Enrique Castell�n. (2020) Cancer stem cell and mesenchymal cell cooperative actions in metastasis progression and hormone resistance in prostate cancer: Potential role of androgen and gonadotropin‑releasing hormone receptors (Review). International Journal of Oncology.
Crossref
Crossref
Sirin Saranyutanon, Sanjeev Kumar Srivastava, Sachin Pai, Seema Singh & Ajay Pratap Singh. (2019) Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope. Cancers 12:1, pages 51.
Crossref
Crossref
Zelin Lei, Xue Bai, Jianxiu Ma & Qin Yu. (2019) Kisspeptin‑13 inhibits bleomycin‑induced pulmonary fibrosis through GPR54 in mice. Molecular Medicine Reports.
Crossref
Crossref
Konstantina Kyritsi, Fanyin Meng, Tianhao Zhou, Nan Wu, Julie Venter, Heather Francis, Lindsey Kennedy, Paolo Onori, Antonio Franchitto, Francesca Bernuzzi, Pietro Invernizzi, Kelly McDaniel, Romina Mancinelli, Domenico Alvaro, Eugenio Gaudio, Gianfranco Alpini & Shannon Glaser. (2017) Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b. The American Journal of Pathology 187:7, pages 1551-1565.
Crossref
Crossref
Ali Aboel Dahab, Dhia El-Hag, Gamal M. Moutamed, Sarah Aboel Dahab, Ramadan Abuknesha & Norman W. Smith. (2016) Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics. Cancer Chemotherapy and Pharmacology 78:3, pages 465-489.
Crossref
Crossref
Shayli Varasteh Moradi, Pegah Varamini & Istvan Toth. (2015) Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs. The AAPS Journal 17:5, pages 1135-1143.
Crossref
Crossref
R. Elancheran, V. L. Maruthanila, M. Ramanathan, S. Kabilan, R. Devi, A. Kunnumakara & Jibon Kotoky. (2015) Recent discoveries and developments of androgen receptor based therapy for prostate cancer. MedChemComm 6:5, pages 746-768.
Crossref
Crossref
Roberta M. Moretti, Marina Montagnani Marelli, Deanne M. Taylor, Paolo G. V. Martini, Monica Marzagalli & Patrizia Limonta. (2014) Gonadotropin-Releasing Hormone Agonists Sensitize, and Resensitize, Prostate Cancer Cells to Docetaxel in a p53-Dependent Manner. PLoS ONE 9:4, pages e93713.
Crossref
Crossref
Barbara Mognetti, Giuseppe La Montagna, Maria Giulia Perrelli, Silvia Marino, Pasquale Pagliaro, Cecilia M. Cracco & Claudia Penna. (2014) Zoledronic Acid and Leuprorelin Acetate, Alone or in Combination, Similarly Reduce Proliferation and Migration of Prostate Cancer Cells In Vitro. International Journal of Medical Biology 1, pages 1-7.
Crossref
Crossref
Patrizia Limonta & Marilena Manea. (2013) Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies. Cancer Treatment Reviews 39:6, pages 647-663.
Crossref
Crossref
Yuri Tolkach, Steven Joniau & Hendrik Van Poppel. (2013)
Luteinizing hormone‐releasing hormone (
LHRH
) receptor agonists vs antagonists: a matter of the receptors?
. BJU International 111:7, pages 1021-1030.
Crossref
Crossref
Peter Hammerer & Stephan Madersbacher. (2013) Reply. BJU International 111:3.
Crossref
Crossref
Gina Lama, Massimiliano Papi, Cristiana Angelucci, Giuseppe Maulucci, Gigliola Sica & Marco De Spirito. (2013) Leuprorelin Acetate Long-Lasting Effects on GnRH Receptors of Prostate Cancer Cells: An Atomic Force Microscopy Study of Agonist/Receptor Interaction. PLoS ONE 8:1, pages e52530.
Crossref
Crossref
Patrizia Limonta, Marina Montagnani Marelli, Stefania Mai, Marcella Motta, Luciano Martini & Roberta M. Moretti. (2012) GnRH Receptors in Cancer: From Cell Biology to Novel Targeted Therapeutic Strategies. Endocrine Reviews 33:5, pages 784-811.
Crossref
Crossref
Catherine A. Sánchez, Alejandro J. Mercado, Héctor R. Contreras, Juan C. Cabezas, Christian C. Huidobro & Enrique A. Castellón. (2012) Pharmacoperone IN3 enhances the apoptotic effect of leuprolide in prostate cancer cells by increasing the gonadotropin-releasing hormone receptor in the cell membrane. Anti-Cancer Drugs 23:9, pages 959-969.
Crossref
Crossref
Laurent Boccon-Gibod, Egbert van der Meulen & Bo-Eric Persson. (2011) An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer. Therapeutic Advances in Urology 3:3, pages 127-140.
Crossref
Crossref
Chen Feng Ji, Lei Yue, Yu Bin Ji & Shi Yong Gao. (2010) Effect of Asparagus saponins on HepG2 apoptosis and mitochondrial membrane potential and ROS level. Effect of Asparagus saponins on HepG2 apoptosis and mitochondrial membrane potential and ROS level.
Mariela Bilotas, Gabriela Meresman, Ricardo Buquet, Carlos Sueldo & Rosa Inés Barañao. (2010) Effect of vascular endothelial growth factor and interleukin-1β on apoptosis in endometrial cell cultures from patients with endometriosis and controls. Journal of Reproductive Immunology 84:2, pages 193-198.
Crossref
Crossref
Xiang Zou, Chen feng Ji & Yu bin Ji. (2009) Effect of Asparagus Saponins on HepG2 Apoptosis and Mitochondrial Membrane Potential and ROS Level. Effect of Asparagus Saponins on HepG2 Apoptosis and Mitochondrial Membrane Potential and ROS Level.
Catherine Sánchez, Patricia Mendoza, Héctor R. Contreras, Jorge Vergara, James A. McCubrey, Christian Huidobro & Enrique A. Castellón. (2009) Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs. The Prostate 69:13, pages 1448-1459.
Crossref
Crossref
Cristiana Angelucci, Gina Lama, Fortunata Iacopino, Silvia Ferracuti, Aldo V. Bono, Robert P. Millar & Gigliola Sica. (2009) GnRH receptor expression in human prostate cancer cells is affected by hormones and growth factors. Endocrine 36:1, pages 87-97.
Crossref
Crossref
Marisa Clementi, Catherine Sánchez, Dixan A. Benitez, Héctor R. Contreras, Christian Huidobro, Juan Cabezas, Cristian Acevedo & Enrique A. Castellón. (2009) Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas. The Prostate 69:10, pages 1025-1033.
Crossref
Crossref
Dong-Ki Kim, Ji Sook Yang, Kaushik Maiti, Jong-Ik Hwang, Kyungjin Kim, Dongseung Seen, Younghee Ahn, Cheolju Lee, Byeong-Cheol Kang, Hyuk Bang Kwon, Jun Cheon & Jae Young Seong. (2009) A Gonadotropin-Releasing Hormone-II Antagonist Induces Autophagy of Prostate Cancer Cells. Cancer Research 69:3, pages 923-931.
Crossref
Crossref
Wai‐Kin So, Jung‐Chien Cheng, Song‐Ling Poon & Peter C. K. Leung. (2008) Gonadotropin‐releasing hormone and ovarian cancer: a functional and mechanistic overview. The FEBS Journal 275:22, pages 5496-5511.
Crossref
Crossref
Elahe A. Mostaghel, Robert B. Montgomery & Daniel W. Lin. (2008) The basic biochemistry and molecular events of hormone therapy. Current Prostate Reports 6:2, pages 47-55.
Crossref
Crossref
D A Benitez, E Pozo-Guisado, M Clementi, E Castellón & P M Fernandez-Salguero. (2007) Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway. British Journal of Cancer 96:10, pages 1595-1604.
Crossref
Crossref
Elahe A. Mostaghel, Robert B. Montgomery & Daniel W. Lin. (2007) The basic biochemistry and molecular events of hormone therapy. Current Urology Reports 8:3, pages 224-232.
Crossref
Crossref